Core Viewpoint - The company is expected to turn a profit in 2025, with a projected net profit of 100 million to 130 million yuan, driven by increased sales prices and volumes [1][2]. Group 1: Recent Developments - The company held a board meeting on February 11, 2026, to review the revised management measures for the implementation of the 2026 restricted stock incentive plan [1]. - The company announced its earnings forecast on January 20, 2026, indicating a significant improvement in financial performance for 2025 [2]. Group 2: Financial Performance - The projected net profit for 2025 is between 100 million and 130 million yuan, marking a turnaround from previous losses [2]. - The anticipated profit increase is attributed to growth in both sales prices and sales volumes [2].
华绿生物发布2025年业绩预告，预计扭亏为盈